A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression ; volume:24 ; number:1 ; day:18 ; month:7 ; year:2024 ; pages:1-11 ; date:12.2024
BMC psychiatry ; 24, Heft 1 (18.7.2024), 1-11, 12.2024
- Creator
-
Pattanaseri, Keerati
Lortrakul, Juthawadee
Jaisin, Kankamol
Srifuengfung, Maytinee
Sa-nguanpanich, Naratip
Viravan, Natee
Pariwatcharakul, Pornjira
Makarasara, Wattanan
Ratta-apha, Woraphat
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12888-024-05951-5
- URN
-
urn:nbn:de:101:1-2410080812555.700285935548
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pattanaseri, Keerati
- Lortrakul, Juthawadee
- Jaisin, Kankamol
- Srifuengfung, Maytinee
- Sa-nguanpanich, Naratip
- Viravan, Natee
- Pariwatcharakul, Pornjira
- Makarasara, Wattanan
- Ratta-apha, Woraphat
- SpringerLink (Online service)
Other Objects (12)
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Personalized use of ketamine and esketamine for treatment-resistant depression
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Personalized use of ketamine and esketamine for treatment-resistant depression
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Personalized use of ketamine and esketamine for treatment-resistant depression
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine